Medicine for hypertension

As per available reports about 41 journals, 8 Conferences, 24 workshops are presently dedicated exclusively to medicine for hypertension and about 482 articles are being published on the current trends in medicine for hypertension. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to medicine for hypertension are being carried out. High blood pressure is a common condition in which the flow of the blood against arteries is high enough that it may be eventually cause health problems, such as heart disease. Choice of treatment will depend on blood pressure level and risk of developing a cardiovascular disease, such as a stroke, heart attack or kidney failure. Many medications known as antihypertensives are available by prescription to lower high blood pressure. Drugs such as calcium channel blockers (CCBs), angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), diuretics and beta-blockers are all considered acceptable alternative therapies in patients with hypertension.

The Journal of Hypertension is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in medicine for hypertension. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Hypertension provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of medicine for hypertension thus bridging the gap between researchers and young scientists.

OMICS Group organizing 5th International Conference on Clinical & Experimental Cardiology (Cardiology-2015) with the theme “Blooming landscapes in cardio research” with a well reputed organizing committee during April 27-29, 2015 at Philadelphia, USA.